
In the name of an “efficient, risk-based approach” to regulation in order to “promote health” through innovation, Gottlieb detailed a number of initiatives underway or soon to be.

In the name of an “efficient, risk-based approach” to regulation in order to “promote health” through innovation, Gottlieb detailed a number of initiatives underway or soon to be.

"We are pitting the enthusiasm of the futurists...against the public health perspective that says ‘be careful what you screen for,’” the prominent genomicist says.

The FDA, GINA, and variants of unknown significance all muddy the waters of genomic research and data storage.

Certainly, Walton believes greatly in the potential of genomics to change medicine at its core, but the obstacles preceding that shift are numerous and substantial, he argued.

"It truly can transform how we diagnose and treat cancer patients. They've just never had these kinds of tools before," says the Hackensack Meridian Health co-CEO.

"If this were a drug that had a survival advantage of this magnitude, it would be retail priced at hundreds of thousands of dollars."

Cerner Corp. nailed down a $4 billion-plus Department of Defense contract in 2015. The deal with the VA bypassed the typical public bidding process.

Trio will pilot program to leverage Watson's computational power to determine value-based treatment options for cancer patients.

Data scientists and clinical researchers collaborate on MiSL, or “Mining Synthetic Lethals,” to identify genetic duos within tumors that allow cancer to survive.

Of all of the conditions that technological innovation has the potential to mitigate, assuage, and aid, vision loss leaves plenty of room for the novel and life-changing.

"My particular joy is in innovation, and trying to innovate before the problem occurs, before the pain is really felt, and having a solution ready for when it does hit," Suit says.

Recent reports of a new team at the FDA that will try to match healthtech's pace of innovation mesh with previous writings by the Administration's recently-appointed head, Scott Gottlieb.

When it was a mere "online bookseller," Amazon invested in 40% of an online pharmacy that didn't quite pan out. Now the preeminint online retail giant, the company is believed to be taking another look at the complex industry.

SCIO Health Analytics' Chief Evangelist argues for the use of analytics to prevent complications and provide true value-based care.

No matter how they safeguard, it’s not a question of whether health systems will suffer a breach but rather when, according to many experts.

Partnership of major national companies launches initiative, encourages President in pursuit of wider adoption of value-based models.

electroCore's device provides mild electrical stimulation to the vagus nerve in order to alleviate headaches.

The Project ECHO programs in New Mexico seek to use mass specialist-to-primary teleconferencing to improve treatment of conditions like diabetes across a vast, rural state.

Equipped with the pancreas and a Fitbit, the children successfully maintained good blood sugar levels despite elevated activity.

A House of Representitives vote on the American Health Care Act did not fall on the seventh anniversary of the signing of the Affordable Care Act. Now it will not occur at all.

The review included nearly 30,000 young patients and found a "small, but significant" effect of mHealth as a viable modality in their treatment.

In the second part of our interview with CCHP director Gutierrez, he speaks about how telehealth policy is evolving nationwide.

Can futuristic-sounding technologies really drive meaningful outcomes that improve the everyday performance of health systems?

"We have to change that dynamic and think about the consumer at the center of the healthcare system," Mario Gutierrez says.

A wide reach and vast accesibility allowed the researchers to see nationwide data and detect trends, but the program suffered from the same natural enthusiasm decay that any mobile app does.

Respected surgeon pens plea in Annals of Surgery urging increased use of electronic prescribing platforms to stem the tide of opiate misuse.

"It’s a constant theme we'll be talking about continuously," Hart says. "Patients are saying "we need this support" and yet very few providers are delivering it. "

New Enterprise Associates boasts a portfolio with more than an alphabet's worth of drug makers and research firms in the fold. It also might boast the new head of the Food and Drug Administration.

Though a preliminary study, the new smartphone-controlled armband performed well in patients with serious migraines.
